These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1734048)

  • 21. Specificity of the immune response to a modified group B meningococcal polysaccharide conjugate vaccine.
    Moore S; Farley EK; Fusco PC; Michon F
    Clin Vaccine Immunol; 2007 Jan; 14(1):106-9. PubMed ID: 17079431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 23. Detection of IgM antibodies to Neisseria meningitidis group A polysaccharide in meningitis patients by direct and antibody capture enzyme-linked immunosorbent assays.
    Sippel JE; Girgis NI
    Am J Trop Med Hyg; 1991 Dec; 45(6):676-82. PubMed ID: 1763793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
    Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
    Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme-linked immunosorbent assay for determination of human antibodies to group C meningococcal polysaccharide.
    Basta MT; Russell H; Guirguis NI; Hafez K; El Kholy A
    Proc Soc Exp Biol Med; 1982 Jan; 169(1):7-11. PubMed ID: 6801668
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial.
    Choo S; Zuckerman J; Goilav C; Hatzmann E; Everard J; Finn A
    Vaccine; 2000 Jun; 18(24):2686-92. PubMed ID: 10781855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of antibodies against meningococcal capsular polysaccharides B and C in enzyme-linked immunosorbent assays: towards an improved surveillance of meningococcal disease.
    Andersen J; Berthelsen L; Lind I
    Clin Diagn Lab Immunol; 1997 May; 4(3):345-51. PubMed ID: 9144375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate.
    Fukasawa LO; Gorla MC; Schenkman RP; Garcia LR; Carneiro SM; Raw I; Tanizaki MM
    Vaccine; 1999 Aug; 17(23-24):2951-8. PubMed ID: 10462229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults.
    Griffiss JM; Brandt BL; Altieri PL; Pier GB; Berman SL
    Infect Immun; 1981 Dec; 34(3):725-32. PubMed ID: 6800954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein.
    Thiesen B; Greenwood B; Brieske N; Achtman M
    Vaccine; 1997 Feb; 15(2):209-19. PubMed ID: 9066040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide.
    Hurpin CM; Carosella ED; Cazenave PA
    Hybridoma; 1992 Dec; 11(6):677-87. PubMed ID: 1284118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological relationship between the capsular polysaccharides of Neisseria meningitidis serogroups Z and 29E.
    Griffiss JM; Brandt BL
    J Gen Microbiol; 1983 Feb; 129(2):447-52. PubMed ID: 6405009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis.
    Pon RA; Lussier M; Yang QL; Jennings HJ
    J Exp Med; 1997 Jun; 185(11):1929-38. PubMed ID: 9166422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoassay of human Neisseria meningitidis serogroup A antibody.
    Diakun KR; Martin DC; Mininni T; Skuse J; Ziembiec N; Quataert S
    Immunol Invest; 1998; 27(4-5):203-20. PubMed ID: 9730082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective immunization against group B meningococci using anti-idiotypic mimics of the capsular polysaccharide.
    Beninati C; Arseni S; Mancuso G; Magliani W; Conti S; Midiri A; Biondo C; Polonelli L; Teti G
    J Immunol; 2004 Feb; 172(4):2461-8. PubMed ID: 14764718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human antibody responses to A and C capsular polysaccharides, IgA1 protease and transferrin-binding protein complex stimulated by infection with Neisseria meningitidis of subgroup IV-1 or ET-37 complex.
    Brieske N; Schenker M; Schnibbe T; Quentin-Millet MJ; Achtman M
    Vaccine; 1999 Feb; 17(7-8):731-44. PubMed ID: 10067678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.
    Anderson EL; Bowers T; Mink CM; Kennedy DJ; Belshe RB; Harakeh H; Pais L; Holder P; Carlone GM
    Infect Immun; 1994 Aug; 62(8):3391-5. PubMed ID: 8039909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children.
    King WJ; MacDonald NE; Wells G; Huang J; Allen U; Chan F; Ferris W; Diaz-Mitoma F; Ashton F
    J Pediatr; 1996 Feb; 128(2):196-202. PubMed ID: 8636811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Group C Neisseria meningitidis variant polysaccharide vaccines in children.
    Steinhoff MC; Lewin EB; Gotschlich EC; Robbins JB
    Infect Immun; 1981 Oct; 34(1):144-6. PubMed ID: 6795122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.
    Dolan KT; Staub JM; Schofield TL; Ahonkhai VI; Ellis RW; Vella PP
    J Immunoassay; 1991; 12(4):543-64. PubMed ID: 1806588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.